The polymeric hybrid micelles have been utilized for the delivery of CpG-ODN and Trp2 to create a nanovaccine for targeting lymph nodes and enhancing the accumulation of cargo in dendritic cells, triggering CD8+ T cell-mediated immune responses and enhancing cancer suppression (melanoma) [577]. The gene discussed is CD8A; the disease is cancer.